Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.07 – $1.14
0% from low
No one on the platform currently holds ANPCY.
No tracked institution reports a position in ANPCY as of their last filing.
No one on the platform has traded ANPCY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3M | +125.0% | $-0.05 | $-0.14–$0.00 | — | 1 |
| 2027 | $5M | +55.6% | $-0.04 | $-0.13–$0.00 | — | 1 |
| 2028 | $8M | +48.2% | $-0.01 | $-0.03–$0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ANPCYCelLBxHealth plc | $0.07 | +0.00% | $22M | — |
| ECGSEco-Growth Strategies Inc. | $0.05 | +2.22% | $3M | — |
| EGRXEagle Pharmaceuticals, Inc. | $0.59 | +466.67% | $8M | — |
| FPCGAvem Health Partners, Inc. | $1025.00 | +0.00% | $10M | — |
| JMPHFLeveljump Healthcare Corp. | $0.04 | +0.00% | $8M | — |
| LVCLFAlgorae Pharmaceuticals Limited | $0.01 | +0.00% | $19M | — |
| MDBIFTrivarX Limited | $0.00 | +0.00% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry